Lettsomian Lecture. Selective cancer therapy: is it attainable with engineered antibodies and gene therapy?
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007116:Immunization, Passive; D009369:Neoplasms / Q000628:therapy*; D011355:Prodrugs / Q000008:administration & dosage; D016499:Radioimmunotherapy